Documentation of off-label use of biologics in Rheumatoid Arthritis
| Autor: | Joachim R. Kalden, Arthur Kavanaugh, Ferrie Breedveld, Joachim Sieper, Philip J. Mease, Roy Fleischman, Josef S. Smolen, Daniel E. Furst |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Very large array
medicine.medical_specialty business.industry Immunology Documentation Off-Label Use medicine.disease Off-label use General Biochemistry Genetics and Molecular Biology Biologic Agents Arthritis Rheumatoid Rheumatology Antirheumatic Agents Rheumatoid arthritis Physical therapy Humans Immunology and Allergy Medicine business Intensive care medicine |
| Zdroj: | Annals of the Rheumatic Diseases. 72:ii35-ii51 |
| ISSN: | 1468-2060 0003-4967 |
| DOI: | 10.1136/annrheumdis-2013-consensusapp |
| Popis: | The ‘Updated Consensus Statement on Biological Agents for the Treatment of Rheumatic Diseases’ represents the consensus and efforts of a worldwide group of experts regarding the use of biologics in Rheumatoid Arthritis. That document details the use of biologics in registered uses for those drugs. However, the biologic agents are used ‘off label’ in a very large array of other rheumatic diseases. To some degree, those uses are based on animal studies and mechanistic rationale but they often … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|